The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 12,755 | 1,305,500 | SH | SOLE | 1,305,500 | 0 | 0 | ||
| APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 1,223 | 372,806 | SH | SOLE | 372,806 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 662 | 165,600 | SH | Call | SOLE | 165,600 | 0 | 0 | |
| ARVINAS INC | COM | 04335A105 | 3,224 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 16,892 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 5,804 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 2,779 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 12,648 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 4,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 1,028 | 3,250 | SH | SOLE | 3,250 | 0 | 0 | ||
| COHERUS BIOSCIENCES INC | COM | 19249H103 | 2,433 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 20,430 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| CUE BIOPHARMA INC | COM | 22978P106 | 1,774 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 4,997 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 3,108 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| INVESCO CURRENCYSHARES EURO | EURO SHS | 46138K103 | 2,173 | 20,830 | SH | SOLE | 20,830 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 14,154 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | 11,051 | 710,000 | SH | SOLE | 710,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 10,477 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 2,850 | 828,459 | SH | SOLE | 828,459 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,678 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 1,467 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 1,745 | 112,695 | SH | SOLE | 112,695 | 0 | 0 | ||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 384 | 208,733 | SH | SOLE | 208,733 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 10,880 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 11,660 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,840 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| MYOVANT SCIENCES LTD | COM | G637AM102 | 4,417 | 585,000 | SH | SOLE | 585,000 | 0 | 0 | ||
| ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 1,341 | 178,109 | SH | SOLE | 178,109 | 0 | 0 | ||
| PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 1,645 | 497,074 | SH | SOLE | 497,074 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 1,608 | 227,827 | SH | SOLE | 227,827 | 0 | 0 | ||
| INVESCO QQQ TR | UNIT SER 1 | 46090E103 | 33,168 | 174,200 | SH | Put | SOLE | 174,200 | 0 | 0 | |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 9,068 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 7,217 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 1,867 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| SELECTA BIOSCIENCES INC | COM | 816212104 | 4,157 | 1,725,000 | SH | SOLE | 1,725,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 2,743 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 37,812 | 146,700 | SH | Put | SOLE | 146,700 | 0 | 0 | |
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 2,475 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 1,968 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 3,333 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
| VIEWRAY INC | COM | 92672L107 | 1,957 | 782,928 | SH | SOLE | 782,928 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 3,960 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 19,236 | 248,400 | SH | Put | SOLE | 248,400 | 0 | 0 | |
| SPDR SER TR | S&P BIOTECH | 78464A870 | 37,876 | 489,100 | SH | Put | SOLE | 489,100 | 0 | 0 | |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,686 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| SELECT SECTOR SPDR TR | SBI HEALTHCARE | 81369Y209 | 13,004 | 146,800 | SH | Call | SOLE | 146,800 | 0 | 0 | |
| SELECT SECTOR SPDR TR | SBI HEALTHCARE | 81369Y209 | 8,672 | 97,900 | SH | Call | SOLE | 97,900 | 0 | 0 | |
| ZOGENIX INC | COM NEW | 98978L204 | 3,710 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||